Literature DB >> 17665762

Implementing immunocontraception in free-ranging African elephants at Makalali conservancy.

A K Delsink1, J J van Altena, D Grobler, H J Bertschinger, J F Kirkpatrick, R Slotow.   

Abstract

The goal of programmes to provide contraception for elephants should be to formulate an approach that does not require the relocation or immobilisation of the same individual year after year, which would be long-lasting and cause minimal disruption to social and reproductive behaviour. The programmes should be simple to administer, safe and cost-effective, and must meet the objectives defined by managers in the field. An immunocontraceptive programme was initiated in a small free-roaming population of elephants at the Greater Makalali Private Game Reserve in Limpopo Province in 2000 to determine whether the porcine zona pellucida (pZP) vaccine can successfully control population sizes. Further objectives were to determine implementation costs and efficiency through a multi-faceted approach. We have demonstrated that immunocontraception meets the objectives set by managers in the field. Minimal social disruption was observed over the course of treatment, with the mode of delivery (ground or aerial vaccinations) determining the degree of stress within herds and speed of resumption of normal movement patterns. Aerial vaccinations resulted in the least disturbance, with target herds being approachable within a day. In 2005, implementation costs were R880-R1000/elephant/year, inclusive of darts, vaccine, helicopter and veterinary assistance. Irrespective of the source or method of vaccine delivery, a non-pregnant elephant is rendered infertile from 1st vaccine administration. The sooner immunocontraception is implemented, the sooner population growth rates can be controlled. pZP contraception is a realistic alternative management tool, particularly if used as part of a long-term management strategy. Mass-darting from the air eliminates the need for detailed individual histories of each elephant or for employing a person to monitor elephants. Thus, implementation of immunocontraception in larger populations is feasible and practical.

Entities:  

Mesh:

Year:  2007        PMID: 17665762     DOI: 10.4102/jsava.v78i1.282

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  4 in total

1.  How immunocontraception can contribute to elephant management in small, enclosed reserves: Munyawana population as a case study.

Authors:  Heleen C Druce; Robin L Mackey; Rob Slotow
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

2.  Longevity of an immunocontraceptive vaccine effect on fecundity in rats.

Authors:  R Pinkham; D Eckery; R Mauldin; M Gomm; F Hill; F Vial; G Massei
Journal:  Vaccine X       Date:  2021-12-27

3.  Evaluation of remote delivery of Passive Integrated Transponder (PIT) technology to mark large mammals.

Authors:  W David Walter; Charles W Anderson; Kurt C Vercauteren
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

4.  Non-invasive assessment of the reproductive cycle in free-ranging female African elephants (Loxodonta africana) treated with a gonadotropin-releasing hormone (GnRH) vaccine for inducing anoestrus.

Authors:  Gabriela Benavides Valades; Andre Ganswindt; Henry Annandale; Martin L Schulman; Henk J Bertschinger
Journal:  Reprod Biol Endocrinol       Date:  2012-08-25       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.